BCDA Company Profile and Key Details

Q: Who are the executives of BCDA?

Dr. Peter A. Altman Ph.D.Chief Executive Officer, Pres & DirectorMr. David McClungChief Financial OfficerMr. Edward M. GillisSenior Vice President of DevicesDr. Sujith ShettyChief Medical Officer and Vice President of Clinical & RegulatoryDr. Ian McNiece Ph.D.Chief Scientific Officer

NASDAQ : BCDA

BioCardia

$0.86

-0.02119998-2.42%

At Close 4:00 PM

$1.05

+0.0806+8.35%

After-Market 05:00 PM

66.37

B-ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

BioCardia, Inc. (BCDA) stock declined over -2.42%, trading at $0.86 on NASDAQ, down from the previous close of $0.88. The stock opened at $0.90, fluctuating between $0.85 and $0.91 in the recent session.

Stock Snapshot

0.8762

Prev. Close

4.96M

Market Cap

0.85

Day Low

-0.94

P/E Ratio

-0.91

EPS (TTM)

-0.42

Cash Flow per Share

0.9

Open

5.8M

Number of Shares

0.91

Day High

78.6%

Free Float in %

-0.07

Book Value

480.51K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jul 16, 2026	0.90	0.91	0.85	0.86	477.63K
Jul 15, 2026	0.83	0.89	0.83	0.88	186.96K
Jul 14, 2026	0.92	0.95	0.80	0.80	744.09K
Jul 13, 2026	0.94	0.95	0.90	0.91	329.58K
Jul 10, 2026	0.90	0.95	0.86	0.91	550.04K
Jul 09, 2026	0.98	1.00	0.89	0.89	597.56K
Jul 08, 2026	0.99	1.03	0.90	0.97	1.06M
Jul 07, 2026	1.16	1.16	1.00	1.01	809.59K
Jul 06, 2026	1.20	1.22	1.17	1.17	250.15K
Jul 02, 2026	1.19	1.24	1.17	1.20	369.17K
Jul 01, 2026	1.22	1.25	1.19	1.19	254.82K
Jun 30, 2026	1.23	1.25	1.13	1.24	547.2K
Jun 29, 2026	1.18	1.26	1.18	1.21	618.72K
Jun 26, 2026	1.06	1.24	1.05	1.20	1.46M
Jun 25, 2026	1.12	1.13	0.99	1.09	4.91M
Jun 24, 2026	0.99	1.09	0.99	1.06	489.55K
Jun 23, 2026	0.95	1.02	0.93	1.00	476.42K
Jun 22, 2026	0.96	0.99	0.87	0.97	1.11M
Jun 18, 2026	0.99	1.03	0.92	0.97	883.88K
Jun 17, 2026	0.86	0.96	0.83	0.95	476.76K

Contact Details

Sunnyvale, CA 94085

United States

https://www.biocardia.com 650 226 0120

About Company

BioCardia, Inc. is a pioneering clinical-stage company dedicated to regenerative medicine, focusing on the development of advanced cellular and cell-derived therapies for a range of cardiac and respiratory ailments. Central to its pipeline is the CardiAMP Cell Therapy System, designed to address heart failure and chronic myocardial ischemia. Additionally, BioCardia is advancing an allogeneic cell therapy program, also targeting cardiac and pulmonary conditions. The company is further exploring a specific allogeneic cell therapeutic platform. This investigational treatment, derived from culture-expanded mesenchymal cells sourced from bone marrow, is currently undergoing Phase I/II trials for patients suffering from ischemic systolic heart failure. Beyond its therapeutic candidates, BioCardia also provides innovative delivery solutions. These include the Helix biotherapeutic delivery system, engineered to precisely administer treatments directly into the heart muscle via an internal penetrating helical needle, and a line of Morph deflectable guides and sheaths. BioCardia maintains its headquarters in Sunnyvale, California.

Stock Peers

ARGX

-4.96-0.57%

argenx SE$857.97 REGN

14.49+2.18%

Regeneron Pharmaceuticals, Inc.$678.94 MDGL

-4.72-0.86%

Madrigal Pharmaceuticals, Inc.$545.53 UTHR

-2.74-0.52%

United Therapeutics Corporation$529.05 VRTX

8.95+1.88%

Vertex Pharmaceuticals Incorporated$486.03 KRYS

-8.45-2.41%

Krystal Biotech, Inc.$341.79 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 ONC

6.16+1.98%

BeOne Medicines AG$317.42 PRAX

-10.22-3.21%

Praxis Precision Medicines, Inc.$308.20 LGND

0.19+0.06%

Ligand Pharmaceuticals Incorporated$296.45

Frequently Asked Questions

What is the current BioCardia, Inc. (BCDA) stock price?

BioCardia, Inc. (NASDAQ: BCDA) stock price is $0.86 in the last trading session. During the trading session, BCDA stock reached the peak price of $0.91 while $0.85 was the lowest point it dropped to. The percentage change in BCDA stock occurred in the recent session was -2.42% while the dollar amount for the price change in BCDA stock was - $0.02.

BCDA's industry and sector of operation?

The NASDAQ listed BCDA is part of Biotechnology industry that operates in the broader Healthcare sector. BioCardia, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of BCDA?

Dr. Peter A. Altman Ph.D.
Chief Executive Officer, Pres & Director
Mr. David McClung
Chief Financial Officer
Mr. Edward M. Gillis
Senior Vice President of Devices
Dr. Sujith Shetty
Chief Medical Officer and Vice President of Clinical & Regulatory
Dr. Ian McNiece Ph.D.
Chief Scientific Officer

How BCDA did perform over past 52-week?

BCDA's closing price is 9.62% higher than its 52-week low of $0.78 where as its distance from 52-week high of $2.42 is -64.67%.

How many employees does BCDA have?

Number of BCDA employees currently stands at 17.

Link for BCDA official website?

Official Website of BCDA is: https://www.biocardia.com

How do I contact BCDA?

BCDA could be contacted at phone 650 226 0120 and can also be accessed through its website. BCDA operates from 320 Soquel Way, Sunnyvale, CA 94085, United States.

How many shares of BCDA are traded daily?

BCDA stock volume for the day was 480.51K shares. The average number of BCDA shares traded daily for last 3 months was 3.17M.

What is the market cap of BCDA currently?

The market value of BCDA currently stands at $4.96M with its latest stock price at $0.86 and 5.8M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	17
Beta	0.44
Sales or Revenue	$477.00K
5Y Sales Change%	-0.846%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	17
Beta	0.44
Sales or Revenue	$477.00K
5Y Sales Change%	-0.846%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

BCDA Company Profile and Key Details

BioCardia

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Earnings & Analyst Outlook

Shareholding & Insider Activity

Company Overview

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Valuation Metrics

Key Takeaways

Price Forecast & Outlook